Millennium Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Millennium Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,000	Closed	-$631K	–	7539
2021 Q3	$631K	Buy	30,000 +10,000	+50%	+$220K	﹤0.01%	5130
2021 Q2	$394K	Buy	20,000 +5,000	+33%	+$117K	﹤0.01%	5497
2021 Q1	$436K	Buy	+15,000	New	+$420K	﹤0.01%	4931

Millennium Management's NGM Position: Q2 2024 in Review

Millennium Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 66,180 shares — an estimated $105K sold.

Millennium Management first reported a position in NGM in Q2 2019 and held it in 18 quarters. The position peaked at $9.46M in Q4 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Millennium Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Millennium Management sold 66,180 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $105K.
Millennium Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
Millennium Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $9.46M in Q4 2021.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.